Apyx Medical (APYX) Income towards Parent Company (2011 - 2026)

Apyx Medical's Income towards Parent Company history runs 15 years deep, the most recent figure standing at -$2.1 million for Q1 2026.

• Quarterly Income towards Parent Company rose 48.63% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.1 million (up 45.91% YoY) and the FY2025 annual result came in at -$14.1 million, up 45.21% from the prior year.
• Income towards Parent Company was -$2.1 million for Q1 2026 at Apyx Medical, up from -$4.3 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at -$1.0 million in Q2 2023 and bottomed at -$9.6 million in Q4 2023.
• A 5-year average of -$5.0 million and a median of -$4.7 million in 2024 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2023 — Income towards Parent Company jumped 81.3% — and 2024, when it plunged 546.32%.
• Apyx Medical's Income towards Parent Company stood at -$6.1 million in 2022, then tumbled by 58.68% to -$9.6 million in 2023, then grew by 28.5% to -$6.9 million in 2024, then soared by 38.09% to -$4.3 million in 2025, then surged by 49.69% to -$2.1 million in 2026.
• Business Quant data shows APYX's Income towards Parent Company at -$2.1 million in Q1 2026, -$4.3 million in Q4 2025, and -$2.0 million in Q3 2025.